genalyte.comHealthcare / Medical DevicesFounded: 2007Funding to Date: $271.69MM
Genalyte is a healthcare diagnostics company which offers rapid and comprehensive testing solutions to healthcare providers and patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/13/2024 | Series C-3 | $20MM | $xx.xx | $283.46MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
22,128,790
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Undisclosed Investors
|
||||||
04/21/2023 | Series C-2 | $17.5MM | $xx.xx | $342.18MM | Boutique Venture Partners, Hbm Healthcare Investments, Invus, Khosla Ventures, Provenio Capital, Redmile Group, Samsara, Verily Life Sciences | |
Price per Share
$xx.xx
Shares Outstanding
15,909,091
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Boutique Venture Partners, Hbm Healthcare Investments, Invus, Khosla Ventures, Provenio Capital, Redmile Group, Samsara, Verily Life Sciences
|
||||||
01/11/2021 | Series C-1 | $51.06MM | $xx.xx | $327.35MM | Hbm Healthcare Investments, Khosla Ventures, Provenio Capital, Redmile Group, Samsara, Verily Life Sciences | |
Price per Share
$xx.xx
Shares Outstanding
46,421,111
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Hbm Healthcare Investments, Khosla Ventures, Provenio Capital, Redmile Group, Samsara, Verily Life Sciences
|
||||||
04/15/2020 | Series C | $166.78MM | $xx.xx | $213.75MM | Hbm Healthcare Investments, Khosla Ventures, Provenio Capital, Redmile Group, Samsara | |
Price per Share
$xx.xx
Shares Outstanding
166,775,414
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Hbm Healthcare Investments, Khosla Ventures, Provenio Capital, Redmile Group, Samsara
|
||||||
11/21/2016 | Series A-2 | $16.35MM | $xx.xx | $33.6MM | Khosla Ventures, Redmile Group | |
Price per Share
$xx.xx
Shares Outstanding
1,634,785
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Khosla Ventures, Redmile Group
|